Within these pages, you will discover articles that showcase our latest discoveries, collaborative projects, and the impact of our open-access approach. This section offers a behind-the-scenes look at the innovative work unfolding at the SGC, featuring contributions from our scientists, partners, and community members. Interested in getting first the latest news from SGC?
By Aled Edwards, SGC CEO
In the early months of 2003, I made a trip to England to interview for the SGC Chief Executive position, which was to be based in Oxford. Prior to the trip, I had agreed with my colleague Cheryl Arrowsmith that it would be an exciting opportunity for…
By Aled Edwards, SGC CEO
The origins of the Structural Genomics Consortium (SGC) can be traced back to 1999 when Rob Cooke (then at GlaxoWellcome) floated an idea past counterparts in other pharmaceutical companies as to whether a pre-competitive consortium in the field of…
The prevailing view in biomedicine and drug discovery is that we need more “innovation”.
At the SGC, we (narrowly) interpret “innovation” to mean novel targets and mechanisms because we believe this sort of innovation will have the greatest impact on unmet medical needs.
To…
Categories